Effects of ex vivo Extracorporeal Membrane Oxygenation Circuits on Sequestration of Antimicrobial Agents

Objectives: Our ex vivo study was designed to determine the sequestration of teicoplanin, tigecycline, micafungin, meropenem, polymyxin B, caspofungin, cefoperazone sulbactam, and voriconazole in extracorporeal membrane oxygenation (ECMO) circuits.Methods: Simulated closed-loop ECMO circuits were pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuan Zhang, Hongbin Hu, Qing Zhang, Qing Ou, Huayou Zhou, Tong Sha, Zhenhua Zeng, Jie Wu, Jingrui Lu, Zhongqing Chen
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/cdb9740f13644df2bc248c88895590b1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cdb9740f13644df2bc248c88895590b1
record_format dspace
spelling oai:doaj.org-article:cdb9740f13644df2bc248c88895590b12021-12-01T22:59:05ZEffects of ex vivo Extracorporeal Membrane Oxygenation Circuits on Sequestration of Antimicrobial Agents2296-858X10.3389/fmed.2021.748769https://doaj.org/article/cdb9740f13644df2bc248c88895590b12021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.748769/fullhttps://doaj.org/toc/2296-858XObjectives: Our ex vivo study was designed to determine the sequestration of teicoplanin, tigecycline, micafungin, meropenem, polymyxin B, caspofungin, cefoperazone sulbactam, and voriconazole in extracorporeal membrane oxygenation (ECMO) circuits.Methods: Simulated closed-loop ECMO circuits were prepared using 2 types of blood-primed ECMO. After the circulation was stabilized, the study drugs were injected into the circuit. Blood samples were collected at 2, 5, 15, 30 min, 1, 3, 6, 12, and 24 h after injection. Drug concentrations were measured by high-performance liquid chromatography-tandem mass spectrometry. Control groups were stored at 4°C after 3, 6, 12, and 24 h immersing in a water bath at 37°C to observe spontaneous drug degradation.Results: Twenty-six samples were analyzed. The average drug recoveries from the ECMO circuits and control groups at 24 h relative to baseline were 67 and 89% for teicoplanin, 100 and 145% for tigecycline, 67 and 99% for micafungin, 45 and 75% for meropenem, 62 and 60% for polymyxin B, 83 and 85% for caspofungin, 79 and 98% for cefoperazone, 75 and 87% for sulbactam, and 60 and 101% for voriconazole, respectively. Simple linear regression showed no significant correlation between lipophilicity (r2 = 0.008, P = 0.225) or the protein binding rate (r2 = 0.168, P = 0.479) of drugs and the extent of drug loss in the ECMO circuits.Conclusions: In the two ECMO circuits, meropenem and voriconazole were significantly lost, cefoperazone was slightly lost, while tigecycline and caspofungin were not lost. Drugs with high lipophilicity were lost more in the Maquet circuit than in the Sorin circuit. This study needs more in vivo studies with larger samples for further confirmation, and it suggests that therapeutic drug concentration monitoring should be strongly considered during ECMO.Yuan ZhangHongbin HuQing ZhangQing OuHuayou ZhouTong ShaZhenhua ZengJie WuJingrui LuZhongqing ChenFrontiers Media S.A.articleantimicrobial agentsextracorporeal membrane oxygenationsequestrationex vivointensive care unitMedicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic antimicrobial agents
extracorporeal membrane oxygenation
sequestration
ex vivo
intensive care unit
Medicine (General)
R5-920
spellingShingle antimicrobial agents
extracorporeal membrane oxygenation
sequestration
ex vivo
intensive care unit
Medicine (General)
R5-920
Yuan Zhang
Hongbin Hu
Qing Zhang
Qing Ou
Huayou Zhou
Tong Sha
Zhenhua Zeng
Jie Wu
Jingrui Lu
Zhongqing Chen
Effects of ex vivo Extracorporeal Membrane Oxygenation Circuits on Sequestration of Antimicrobial Agents
description Objectives: Our ex vivo study was designed to determine the sequestration of teicoplanin, tigecycline, micafungin, meropenem, polymyxin B, caspofungin, cefoperazone sulbactam, and voriconazole in extracorporeal membrane oxygenation (ECMO) circuits.Methods: Simulated closed-loop ECMO circuits were prepared using 2 types of blood-primed ECMO. After the circulation was stabilized, the study drugs were injected into the circuit. Blood samples were collected at 2, 5, 15, 30 min, 1, 3, 6, 12, and 24 h after injection. Drug concentrations were measured by high-performance liquid chromatography-tandem mass spectrometry. Control groups were stored at 4°C after 3, 6, 12, and 24 h immersing in a water bath at 37°C to observe spontaneous drug degradation.Results: Twenty-six samples were analyzed. The average drug recoveries from the ECMO circuits and control groups at 24 h relative to baseline were 67 and 89% for teicoplanin, 100 and 145% for tigecycline, 67 and 99% for micafungin, 45 and 75% for meropenem, 62 and 60% for polymyxin B, 83 and 85% for caspofungin, 79 and 98% for cefoperazone, 75 and 87% for sulbactam, and 60 and 101% for voriconazole, respectively. Simple linear regression showed no significant correlation between lipophilicity (r2 = 0.008, P = 0.225) or the protein binding rate (r2 = 0.168, P = 0.479) of drugs and the extent of drug loss in the ECMO circuits.Conclusions: In the two ECMO circuits, meropenem and voriconazole were significantly lost, cefoperazone was slightly lost, while tigecycline and caspofungin were not lost. Drugs with high lipophilicity were lost more in the Maquet circuit than in the Sorin circuit. This study needs more in vivo studies with larger samples for further confirmation, and it suggests that therapeutic drug concentration monitoring should be strongly considered during ECMO.
format article
author Yuan Zhang
Hongbin Hu
Qing Zhang
Qing Ou
Huayou Zhou
Tong Sha
Zhenhua Zeng
Jie Wu
Jingrui Lu
Zhongqing Chen
author_facet Yuan Zhang
Hongbin Hu
Qing Zhang
Qing Ou
Huayou Zhou
Tong Sha
Zhenhua Zeng
Jie Wu
Jingrui Lu
Zhongqing Chen
author_sort Yuan Zhang
title Effects of ex vivo Extracorporeal Membrane Oxygenation Circuits on Sequestration of Antimicrobial Agents
title_short Effects of ex vivo Extracorporeal Membrane Oxygenation Circuits on Sequestration of Antimicrobial Agents
title_full Effects of ex vivo Extracorporeal Membrane Oxygenation Circuits on Sequestration of Antimicrobial Agents
title_fullStr Effects of ex vivo Extracorporeal Membrane Oxygenation Circuits on Sequestration of Antimicrobial Agents
title_full_unstemmed Effects of ex vivo Extracorporeal Membrane Oxygenation Circuits on Sequestration of Antimicrobial Agents
title_sort effects of ex vivo extracorporeal membrane oxygenation circuits on sequestration of antimicrobial agents
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/cdb9740f13644df2bc248c88895590b1
work_keys_str_mv AT yuanzhang effectsofexvivoextracorporealmembraneoxygenationcircuitsonsequestrationofantimicrobialagents
AT hongbinhu effectsofexvivoextracorporealmembraneoxygenationcircuitsonsequestrationofantimicrobialagents
AT qingzhang effectsofexvivoextracorporealmembraneoxygenationcircuitsonsequestrationofantimicrobialagents
AT qingou effectsofexvivoextracorporealmembraneoxygenationcircuitsonsequestrationofantimicrobialagents
AT huayouzhou effectsofexvivoextracorporealmembraneoxygenationcircuitsonsequestrationofantimicrobialagents
AT tongsha effectsofexvivoextracorporealmembraneoxygenationcircuitsonsequestrationofantimicrobialagents
AT zhenhuazeng effectsofexvivoextracorporealmembraneoxygenationcircuitsonsequestrationofantimicrobialagents
AT jiewu effectsofexvivoextracorporealmembraneoxygenationcircuitsonsequestrationofantimicrobialagents
AT jingruilu effectsofexvivoextracorporealmembraneoxygenationcircuitsonsequestrationofantimicrobialagents
AT zhongqingchen effectsofexvivoextracorporealmembraneoxygenationcircuitsonsequestrationofantimicrobialagents
_version_ 1718404070169903104